A detailed history of Plato Investment Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Plato Investment Management LTD holds 16,804 shares of LLY stock, worth $12.7 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
16,804
Previous 15,323 9.67%
Holding current value
$12.7 Million
Previous $13.9 Billion 7.2%
% of portfolio
1.21%
Previous 1.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$772.14 - $960.02 $1.14 Million - $1.42 Million
1,481 Added 9.67%
16,804 $14.9 Billion
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $567,573 - $711,778
783 Added 5.39%
15,323 $13.9 Billion
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $8.02 Million - $10.7 Million
13,539 Added 1352.55%
14,540 $17.3 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $525,715 - $619,749
1,001 New
1,001 $584 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.